BridgeBio Pharma Inc

NAS:BBIOHealthcareNASDAQ:NBINASDAQ:NQUSMG

$67.94+2.33%At closeAt close · Tue 20 Oct · ≈ AED 249.51 · Market cap $13.28B · Next earnings Wed 28 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	95.5%	95.6%	73.7%	98.3%	94.4%	—	—
Operating margin	−5,752.0%	−827.1%	−659.6%	−6,528.8%	−267.2%	−113.3%	−113.3%	+0.0 pts
Net margin	−5,439.7%	−806.9%	−619.7%	−6,913.9%	−241.4%	−145.3%	−144.4%	+0.9 pts
EBITDA margin	−5,665.9%	−765.7%	−511.9%	−6,078.3%	−196.9%	−134.0%	—	—
Return on equity	−774.9%	64.6%	38.4%	47.5%	36.5%	35.1%	34.9%	−0.2 pts
Return on assets	−63.8%	−55.5%	−77.2%	−117.7%	−58.3%	−77.9%	−77.4%	+0.5 pts
Return on capital employed	−78.0%	−65.7%	−102.1%	−150.9%	−77.5%	−87.8%	—	—
Debt / equity	8.6×	−2.0×	−1.4×	−1.3×	−1.2×	−1.3×	−1.3×	+0.0%
Debt / assets	70.5%	170.4%	276.6%	318.4%	188.2%	291.5%	—	—
Interest coverage	−12.9×	−12.3×	−6.4×	−7.5×	−6.0×	−10.7×	—	—
Current ratio	6.7×	6.6×	4.5×	3.3×	4.7×	2.6×	2.6×	+0.0%
Quick ratio	6.7×	6.6×	4.5×	3.3×	4.7×	2.5×	—	—
Cash ratio	3.7×	2.9×	3.1×	2.6×	4.4×	2.0×	2.0×	+0.0%
Asset turnover	0.0×	0.1×	0.1×	0.0×	0.2×	0.5×	—	—
Inventory turnover	—	—	—	—	—	1.1×	—	—
Receivables turnover	—	3.5×	4.5×	5.3×	47.0×	3.6×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.